LunaRich is a breakthrough nutritional ingredient that optimizes bioactive lunasin more than any other source available today.  It marks the culmination of an extensive research and development process that began with the discovery of the lunasin peptide in 1996 by Dr. Alfredo Galvez. Lunasin is now one of the most heavily researched and scientifically supported nutritional compounds available today. Lunasin a peptide found naturally in soy is the first nutritional compound identified to work at the epigenetic level to promote optimal cell health.

Reliv’s non-GMO LunaRich delivers five to ten times the amount of lunasin that provides many of soy’s documented health benefits through epigenetics. Numerous studies demonstrate lunasin’s superior support for cancer-preventive effects, cardiovascular health, immune system support, significant anti-inflammatory properties, anti-aging, skin health, and more…

LunaRich is a Reliv-exclusive nutritional ingredient with multiple patents protecting the technology as it relates to enhancing lunasin bioactivity and its superior ability to deliver bioactive lunasin to the body. “This patent enhancement is the latest exciting development in the LunaRich story,” said Dr. Carl W. Hastings, Reliv vice chairman and chief scientific officer. “Ingredients like LunaRich that boast a spectrum of nutritional technologies often require continual patent updates, and LunaRich’s unique ability to be absorbed by the body is essential to its unparalleled efficacy. Reliv is committed to securing the strongest patent portfolio possible for this remarkable nutritional ingredient.”

Reliv holds an additional patent related to LunaRich’s mechanism of action for lowering cholesterol. Learn more about the cholesterol lowering properties of LunaRich.